SARS-CoV-2 Delta Variant Pseudovirus | 95-203

SARS-CoV-2 Delta Variant Pseudovirus | 95-203 | Gentaur UK, US & Europe Distribution

Product Type: Pseudovirus

Research Area: Infectious Disease, COVID-19

Host Species: N/A

Species Reactivity: N/A

Homology: N/A

Immunogen: N/A

Tested Application: Neut, Viral Infection

Predicted MW: N/A

Purification: N/A

Clonality: N/A

Clone: N/A

Isotype: N/A

Conjugate: N/A

Physical State: Liquid

Buffer: DMEM/10% FBS

Concentration: N/A

Storage: The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.

Additional Names: Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Delta variant spike, Delta variant pseudovirus, Delta, pseudovirus reporter, reporter virus particle

Background: SARS-CoV-2 Delta Pseudovirus uses HIV pseudotyped with SARS-CoV-2 spike protein and firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.

Shipping Condition: Dry Ice

Source: HEK293 cells

Species: SARS-CoV-2 (COVID-19) Spike pseudovirus

Peptide Location: N/A

By Source: Human Cells

By Species: Other

Recombinant Protein Sequence: Delta Variant Spike Met 1 - Cys 1252 (T19R, T95I, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R, D950N)

Badges: New